孕婦服用益生菌是否能預防嬰兒異位性皮膚炎之發生?Can the use of probiotics in pregnant women prevent the development of atopic dermatitis in infants?

640 1 95

2024-02-15 已刊登
新刊登 綜 整 預防/治療/介入類型

作  者

張翠如* 劉芝秀 陳玉麗* 林月娥 林幼麗 楊惠晶

文章類別

A 類:實證健康照護綜整

問題類型

治療/預防性問題

健康狀況

皮膚系統 (Dermatology)  婦產科與婦女健康 (Obstetrics, Gynecology and Women's Health)  兒科醫學 (Pediatrics)  

治療/介入措施

其他(Others) - 益生菌

專長類別

婦兒及家庭

中文關鍵詞

#孕婦 #益生菌 #異位性皮膚炎 #預防

英文關鍵詞

#pregnancy woman # probiotic # atopic dermatitis # prevention

機構名稱

長庚醫療財團法人台北長庚紀念醫院

申請單位

台北長庚紀念醫院

中文摘要

形成臨床提問:
異位性皮膚炎為嬰兒常見慢性、復發性皮膚疾病。臨床現況對嬰兒異位性皮膚炎多以藥物為主要治療方式,孕婦聽聞益生菌能預防嬰兒發生異位性皮膚炎,故詢問是否能在懷孕期間服用益生菌,預防生出異位性皮膚炎的寶寶,因此引發作者的動機。藉由文獻搜尋,設定相關PICO預防性問題,探討孕婦 (P) 服用益生菌 (I) 是否能預防嬰兒發生異位性皮膚炎 (O),以利臨床做出較符合實證的建議。
文獻搜尋的方法與分析:
依實證步驟確立PICO問題:孕婦服用益生菌是否能預防嬰兒異位性皮膚炎之發生。設定關鍵字及同義字P:pregnancy woman、pregnant women、maternal;I:probiotic*、prebiotic*、synbiotics、Lactobacillus、Bifidobacterium;O:atopic dermatitis、atopic eczema、allergic eczema、infant*、 newborn*、bab*、prevent*。搜尋電子資料庫包含Cochrane Library、PubMed、Embase、華藝線上圖書館,P及I的關鍵字分別以布林邏輯OR聯集、再以AND交集,無語言限制,限制Humans,研究類型以Systematic Review and Meta analysis 優先,其次為Randomized Controlled Trial,設定5年內 (2018年至2022年)。依據文獻納入排除標準進行文獻篩選,最後選定2篇系統性文獻回顧及統合分析文章進行評讀。
文獻的品質評讀:
納入2篇系統性文獻回顧及統合分析,評讀工具採用2018年版「CASP systematic Review Checklist」,文獻品質證據等級採用牛津實證醫學中心證據等級表「Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence」,經評讀後確認此2篇系統性文獻回顧及統合分析的證據等級皆為Level 1。
結果、結論與建議:
藉實證醫學手法得知,孕婦懷孕期間吃益生菌,持續服用至嬰兒出生6個月,可預防嬰兒異位性皮膚炎之發生。此兩篇文獻結果皆顯示孕婦服用混合菌株益生菌,比單一菌株益生菌對預防嬰兒異位性皮膚炎發生之成效顯著。另外,在Jiang et al. (2020)系統性文獻回顧結果顯示,孕婦在懷孕第三孕期開始服用益生菌,分娩後產婦持續服用至生產後6個月,對照組嬰兒發生異位性皮膚炎的勝算是實驗組的0.51倍(OR 0.51; 95% CI 0.32-0.84),達統計上顯著差異 (p=.008)。 然而,此2篇系統性文獻回顧中納入的研究,其使用的益生菌菌株、劑量均不同。另外,益生菌雖然在醫院是處方藥,但在坊間屬於保健食品,從一般藥局購得的益生菌其種類及劑量多元,成效也可能不一。期待未來的研究可以針對不同種類益生菌及使用劑量進行進一步的研究,以確認不同菌株益生菌在預防異位性皮膚炎之成效,提供臨床參考。

英文摘要

Ask an answerable question (PICO):
Atopic dermatitis is a chronic and recurrent skin condition commonly seen in infants. In clinical practice, medication is the main treatment for atopic dermatitis in infants. One pregnant woman expressed that she heard probiotics could help prevent the development of atopic dermatitis in infants. She then asked if she could take probiotics during her pregnancy to prevent giving birth to a baby with atopic dermatitis. The query triggered the present study. Through literature search and exploration of relevant PICO questions, this study was aimed to explore whether the pregnant women (P) take probiotics (I) can prevent development of atopic dermatitis in infants (O). Atopic dermatitis is a chronic and recurrent skin condition commonly observed in infants. In clinical practice, medication serves as the primary treatment for atopic dermatitis. A pregnant woman recently inquired about the potential preventive benefits of probiotics against the development of atopic dermatitis in infants. By addressing pertinent PICO questions and conducting a thorough systematic literature search, the study aims to investigate whether pregnant women (P) taking probiotics (I) can prevent the development of atopic dermatitis in infants (O).
The Method and Analysis of Literature Review:
A PICO question was established through empirical steps: Can a pregnant woman take probiotics to prevent development of atopic dermatitis in infants. This study used keywords and synonyms to set P as pregnancy woman, pregnant women, maternal; I as probiotic*, prebiotic*, synbiotics, Lactobacillus, Bifidobacterium; O as atopic dermatitis, atopic eczema, allergic eczema, infant*, newborn*, ansd bab*. Boolean Logic was used to form a union through OR and an intersection through AND. Four electronic journal databases, which were Cochrane Library, PubMed, Embase, and Airiti Library were searched for relevant evidence. The scope was limited to studies regarding humans, randomized controlled trial, systematic review, and meta-analysis written in English or Chinese. The publication years were limited to within the recent 5 years (from 2018 to 2022). The inclusion criteria were set to be studies corresponding to keywords. After literature screening, two systematic review and meta-analysis studies were selected for critical appraisal. The keywords and synonyms were used for literature esarch, with P (pregnancy woman, pregnant women, maternal); I (probiotic*, prebiotic*, synbiotics, Lactobacillus, Bifidobacterium); and O (atopic dermatitis, atopic eczema, allergic eczema, infant*, newborn*, ansd bab*). Boolean Logic was employed to create a union through OR and an intersection through AND. Cochrane Library, PubMed, Embase, and Airiti Library were systematically searched for relevant evidence. We restricted the studies involving humans, randomized controlled trials, systematic reviews / meta-analyses, and written in English or Chinese. The publication years were limited to the most recent 5 years (from 2018 to 2022). Finally, two systematic review and meta-analysis studies were selected for critical appraisal.
Critical Appraisal:
Two systematic review and meta-analysis studies were selected for critical appraisal. The 2018 version of Critical Appraisal Skill Programme (CASP), namely, CASP Systematic Review Checklist (2018) was adopted. The levels of evidence of the studies were based on the Oxford Centre for Evidence-based Medicine 2011 Levels of Evidence. The levels of evidence of the two studies were both Level 1. After critical appraisal, the studies were of Level A according to Oxford suggestions. Two systematic review and meta-analysis studies were selected for critical appraisal. The Critical Appraisal Skills Programme (CASP) Systematic Review Checklist (2018) was utilized. The levels of evidence for the studies were determined following the Oxford Centre for Evidence-based Medicine (2011). Both studies assessed were categorized as Level 1 evidence.
Results, Conclusions and Recommendations:
The evidence-based appraisal results revealed that when pregnant women begin taking probiotics during pregnancy and continue to take probiotics to the 6th month after delivery, the odds of infants in the control group developing atopic dermatitis were 0.51 times that of the experimental group (OR 0.51; 95% CI 0.32-0.84), reached a statistically significant difference (p=.008). As a result of that atopic dermatitis can be prevented in infants when probiotics are absorbed through breastfeeding. The selected studies involved mixed use of probiotic strains to prevent atopic dermatitis in infants. The effectiveness of mixed use of strains was more significant than that of a single strain of probiotics. In addition, the results of the systematic review and meta-analysis by Jiang et al. (2020), the incidence of atopic dermatitis in infants can be reduced if pregnant women start to take probiotics in the third trimester and continue to take them until 6 months after delivery. The results shown that pregnant women take probiotic intake during pregnancy and continue until the sixth month after delivery, the odds of infants in the control group developing atopic dermatitis were 0.51 times that of the experimental group (OR 0.51; 95% CI 0.32-0.84), demonstrating a statistically significant difference (p=.008). Additionally, according to Jiang et al. (2020) study, the incidence of atopic dermatitis in infants can be reduced if pregnant women start taking probiotics in the third trimester and continue until 6 months after delivery. However, the two studies undergoing critical appraisal had different probiotic strains and doses. In addition, although probiotics are prescribed medicines in hospitals, but it is a kind of health food in the over-the-counter medications, which can be purchased from general pharmacies. Due to the diverse content of probiotics, the effects may vary. In the future, more studies should explore the effectiveness of different strains of probiotics on preventing and treating atopic dermatitis for providing clinical reference. However, the included studies employed different probiotic strains and doses. Furthermore, the probiotics are also available as health food over-the-counter medications, purchasable from general pharmacies. Due to the diverse content of probiotics, the effects may vary. Therefore, future studies explore the effectiveness of different strains and doses of probiotics in preventing atopic dermatitis among infants are needed.